Open AccessPatients with CKD-5D and COVID infection. Individual organizational and clinical issues of therapy
Author(s) -
П В Моринец,
А. С. Навасардян,
E.A. Strebkova,
П Е Комаров,
Svetlana I. Popova,
О В Ушакова,
Е. А. Морозова
Publication year - 2021
Publication title -
vestnik medicinskogo instituta «reaviz». reabilitaciâ, vrač i zdorovʹe/vestnik medicinskogo instituta "reaviz". reabilitaciâ, vrač i zdorovʹe
Language(s) - English
Resource type - Journals
eISSN - 2782-1579
pISSN - 2226-762X
DOI - 10.20340/vmirvz.2021.2.covid.1
Subject(s) - renal replacement therapy , concomitant , medicine , nephrology , intensive care medicine , covid-19 , kidney disease , pandemic , disease , infectious disease (medical specialty) , dialysis
New coronavirus infection (COVID-19) – a serious medical and social problem. Despite the achievement of certain successes in the treatment of patients with COVID-19, there is a need to develop special clinical and organizational approaches in patients with CKD who are on renal replacement therapy and are at special risk due to the course of the underlying disease and concomitant pathology. The article presents the experience of the Samara Regional Center of Nephrology and Dialysis of the Samara Regional Clinical Hospital named after V.D. Seredavin during the pandemic, as well as the features of the management of patients with stage 5 chronic kidney disease undergoing renal replacement therapy in the infectious department to provide MP to patients with COVID-19. Patients with CKD require increased attention, treatment of coronavirus infection (both specific and concomitant) should be carried out in full, while observing the regimens and dosage regimens of drugs and their combinations.